Table 2 Average percentages of SCFA and BCFA per condition at the end of the intervention (T72)
|  | 5-FU | 5-FU + M1 | 5-FU + M2 | 5-FU + M3 | 5-FU + M4 | Control |
|---|---|---|---|---|---|---|
Acetate % of total SCFA | 49.4% | 65.5% | 65.5% | 66.4% | 63.5% | 36.9% |
Propionate % of total SCFA | 16.8% | 5.6% | 8.9% | 4.1% | 9.9% | 25.3% |
Butyrate % of total SCFA | 31.9% | 28.5% | 24.8% | 29.2% | 25.8% | 35.0% |
Valerate % of total SCFA | 1.9% | 0.4% | 0.8% | 0.3% | 0.8% | 2.9% |
Iso-butyrate % of total BCFA | 30.6% | 18.2% | 21.9% | 22.4% | 21.7% | 31.1% |
Iso-valerate % of total BCFA | 69.5% | 81.8% | 78.1% | 77.6% | 78.3% | 68.9% |